Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
- PMID: 18204840
- DOI: 10.1007/s00280-007-0676-4
Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
Abstract
Purpose: For the development of a safe and effective dual inhibitor of anticancer drug efflux transporters P-glycoprotein and multidrug resistance protein 1 (MRP1) to conquer multidrug resistance, we investigated the effects of dietary phytochemicals on the functions of P-glycoprotein and MRP1.
Methods: The effects of dietary phytochemicals on the functions of P-glycoprotein and MRP1 were investigated using P-glycoprotein-overexpressing human carcinoma KB-C2 cells and human MRP1 gene-transfected KB/MRP cells. The effects of natural compounds found in dietary supplements, herbs, and foods such as sesame, ginkgo, soybean, and licorice were evaluated.
Results: The accumulation of daunorubicin, a fluorescent substrate of P-glycoprotein, increased in the presence of sesamin, ginkgolic acid, matairesinol, glycyrrhetinic acid, glabridin, and phyllodulcin in KB-C2 cells. Glycyrrhetinic acid and matairesinol also increased the accumulation of calcein, a fluorescent substrate of MRP1, in KB/MRP cells. KB-C2 and KB/MRP cells were sensitized to anticancer drugs by glycyrrhetinic acid, showing that glycyrrhetinic acid reverses multidrug resistance. The verapamil-stimulated P-glycoprotein ATPase activity was inhibited by glycyrrhetinic acid. Glycyrrhetinic acid stimulated the ATPase activity of MRP1.
Conclusion: These results suggest that dietary phytochemicals, such as glycyrrhetinic acid found in licorice, have dual inhibitory effects on P-glycoprotein and MRP1 and might become useful to enhance the efficacy of cancer chemotherapy.
Similar articles
-
Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1.Eur J Pharmacol. 2008 Dec 14;600(1-3):45-9. doi: 10.1016/j.ejphar.2008.10.025. Epub 2008 Oct 21. Eur J Pharmacol. 2008. PMID: 18955043
-
Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals.Pharmacol Res. 2010 Mar;61(3):259-63. doi: 10.1016/j.phrs.2009.11.010. Epub 2009 Nov 26. Pharmacol Res. 2010. PMID: 19944162
-
Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.Cancer Res. 2001 May 15;61(10):4030-7. Cancer Res. 2001. PMID: 11358822
-
Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.Med Res Rev. 2005 Jul;25(4):453-72. doi: 10.1002/med.20032. Med Res Rev. 2005. PMID: 15834856 Review.
-
P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.J Ethnopharmacol. 2012 Jun 1;141(2):557-70. doi: 10.1016/j.jep.2011.08.053. Epub 2011 Sep 21. J Ethnopharmacol. 2012. PMID: 21963565 Review.
Cited by
-
Quality by design-based development and optimization of fourth-generation ternary solid dispersion of standardized Piper longum extract for melanoma therapy.Drug Deliv Transl Res. 2023 Dec;13(12):3094-3131. doi: 10.1007/s13346-023-01375-y. Epub 2023 Jun 9. Drug Deliv Transl Res. 2023. PMID: 37294426
-
Metabolomics Analysis Reveals Novel Targets of Chemosensitizing Polyphenols and Omega-3 Polyunsaturated Fatty Acids in Triple Negative Breast Cancer Cells.Int J Mol Sci. 2023 Feb 23;24(5):4406. doi: 10.3390/ijms24054406. Int J Mol Sci. 2023. PMID: 36901842 Free PMC article.
-
Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects.Onco Targets Ther. 2022 Nov 30;15:1419-1448. doi: 10.2147/OTT.S366630. eCollection 2022. Onco Targets Ther. 2022. PMID: 36474507 Free PMC article. Review.
-
Glycyrrhizin as a Nitric Oxide Regulator in Cancer Chemotherapy.Cancers (Basel). 2021 Nov 17;13(22):5762. doi: 10.3390/cancers13225762. Cancers (Basel). 2021. PMID: 34830916 Free PMC article. Review.
-
CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas.Drug Deliv. 2021 Dec;28(1):2205-2217. doi: 10.1080/10717544.2021.1989087. Drug Deliv. 2021. PMID: 34662257 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
